Asimov
Asimov is seeking a Principal Scientist to lead the Lentiviral Vector Cell Line Development team in Boston, MA, blending strategic leadership with hands-on experimentation to drive the platform's roadmap and scientific vision. The role involves creating stable producer cell lines for lentiviral vector therapeutics, innovating next-generation workflows, and serving as the primary technical contact for customer and commercial projects. This position offers a unique opportunity to work at a forward-thinking synthetic biology startup and help build the future of biological engineering.
Headquarters
Boston, Massachusetts, United States
Company Size
11-50 employees
Founded
2017
Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Asimov.
Scientist, Biologics Cell Line Development
Ashby
Associate Principal Scientist, Vector Engineering and Cell Line Development
AstraZeneca
Senior Scientist/Principal Scientist, Biologics Cell Line Development
Ashby
Senior Scientist Vector Engineering
AstraZeneca
Director Vector Engineering
AstraZeneca
Senior Scientist Vector Engineering
AstraZeneca